EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

Core Viewpoint - EUDA Health Holdings Limited has amended its warrant agreement with Streeterville Capital, reducing the exercise price and minimum closing price for forced exercise, aligning with current market conditions while maintaining its long-term strategy [1][2][3] Group 1: Warrant Amendment Details - The exercise price of the warrant has been reduced from US$4.00 per share to US$2.00 per share [2] - The minimum closing price required to trigger a forced exercise has been lowered from US$6.00 to US$3.00 [2] - All other terms of the warrant remain unchanged [2] Group 2: Company Overview and Strategy - EUDA Health Holdings Limited is a leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China [3] - The company aims to address the healthcare needs of over 1.8 billion people in the region, with a strategic focus on the longevity sector [3] - EUDA is committed to transforming healthcare from reactive treatment to proactive, longevity-focused care through innovative and accessible health solutions [3]